Stress Urinary Incontinence for Female Patients (CGM MUIT-2301)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age19+
SponsorCeragem Clinical Inc.

About this trial

This study is a multicenter, prospective, randomized, double-blind, sham-controlled clinical trial conducted in female patients with stress urinary incontinence.

Eligibility criteria

Qualifiers

Patients with urine leakage of ≥1 g on the standardized pad test

Disqualifiers

Patients with mixed urinary incontinence with predominant urgency urinary incontinence

Patients with stress urinary incontinence

Patients with overflow urinary incontinence

Trial design

Treatments tested in this trial

  • Ceragem Innerfit medi-tech

Treatment groups

96 Participants
are divided into 2 treatment groups

Sponsors and collaborators